1012 related articles for article (PubMed ID: 8620493)
1. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH
Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493
[TBL] [Abstract][Full Text] [Related]
2. Constitutive expression of a truncated INT3 gene in mouse mammary epithelium impairs differentiation and functional development.
Smith GH; Gallahan D; Diella F; Jhappan C; Merlino G; Callahan R
Cell Growth Differ; 1995 May; 6(5):563-77. PubMed ID: 7544153
[TBL] [Abstract][Full Text] [Related]
3. Mammary development and tumorigenesis in mice expressing a truncated human Notch4/Int3 intracellular domain (h-Int3sh).
Raafat A; Bargo S; Anver MR; Callahan R
Oncogene; 2004 Dec; 23(58):9401-7. PubMed ID: 15531924
[TBL] [Abstract][Full Text] [Related]
4. The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4).
Gallahan D; Callahan R
Oncogene; 1997 Apr; 14(16):1883-90. PubMed ID: 9150355
[TBL] [Abstract][Full Text] [Related]
5. Kit and PDGFR-alpha activities are necessary for Notch4/Int3-induced tumorigenesis.
Raafat A; Zoltan-Jones A; Strizzi L; Bargo S; Kimura K; Salomon D; Callahan R
Oncogene; 2007 Feb; 26(5):662-72. PubMed ID: 16878155
[TBL] [Abstract][Full Text] [Related]
6. Whey acidic protein extrinsically expressed from the mouse mammary tumor virus long terminal repeat results in hyperplasia of the coagulation gland epithelium and impaired mammary development.
Hennighausen L; McKnight R; Burdon T; Baik M; Wall RJ; Smith GH
Cell Growth Differ; 1994 Jun; 5(6):607-13. PubMed ID: 7522033
[TBL] [Abstract][Full Text] [Related]
7. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
Robinson GW; Wagner KU; Hennighausen L
Oncogene; 2001 Oct; 20(48):7115-9. PubMed ID: 11704837
[TBL] [Abstract][Full Text] [Related]
8. Ectopic TGF beta 1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population.
Kordon EC; McKnight RA; Jhappan C; Hennighausen L; Merlino G; Smith GH
Dev Biol; 1995 Mar; 168(1):47-61. PubMed ID: 7883078
[TBL] [Abstract][Full Text] [Related]
9. Understanding mammary gland development through the imbalanced expression of growth regulators.
Robinson GW; Smith GH; Gallahan D; Zimmer A; Furth PA; Hennighausen L
Dev Dyn; 1996 Jun; 206(2):159-68. PubMed ID: 8725283
[TBL] [Abstract][Full Text] [Related]
10. Expression of a viral oncoprotein during mammary gland development alters cell fate and function: induction of p53-independent apoptosis is followed by impaired milk protein production in surviving cells.
Li M; Hu J; Heermeier K; Hennighausen L; Furth PA
Cell Growth Differ; 1996 Jan; 7(1):3-11. PubMed ID: 8788028
[TBL] [Abstract][Full Text] [Related]
11. SV40 T-antigen induces breast cancer formation with a high efficiency in lactating and virgin WAP-SV-T transgenic animals but with a low efficiency in ovariectomized animals.
Santarelli R; Tzeng YJ; Zimmermann C; Guhl E; Graessmann A
Oncogene; 1996 Feb; 12(3):495-505. PubMed ID: 8637705
[TBL] [Abstract][Full Text] [Related]
12. Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis.
Raafat A; Lawson S; Bargo S; Klauzinska M; Strizzi L; Goldhar AS; Buono K; Salomon D; Vonderhaar BK; Callahan R
Oncogene; 2009 Jan; 28(2):219-30. PubMed ID: 18836481
[TBL] [Abstract][Full Text] [Related]
13. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells.
Smith GH; Sharp R; Kordon EC; Jhappan C; Merlino G
Am J Pathol; 1995 Oct; 147(4):1081-96. PubMed ID: 7573353
[TBL] [Abstract][Full Text] [Related]
15. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.
Morini M; Astigiano S; Mora M; Ricotta C; Ferrari N; Mantero S; Levi G; Rossini M; Barbieri O
Oncogene; 2000 Dec; 19(52):6007-14. PubMed ID: 11146552
[TBL] [Abstract][Full Text] [Related]
16. Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma.
Manhès C; Kayser C; Bertheau P; Kelder B; Kopchick JJ; Kelly PA; Touraine P; Goffin V
J Endocrinol; 2006 Aug; 190(2):271-85. PubMed ID: 16899561
[TBL] [Abstract][Full Text] [Related]
17. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
Krane IM; Leder P
Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899
[TBL] [Abstract][Full Text] [Related]
18. Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-beta1 expression.
Boulanger CA; Wagner KU; Smith GH
Oncogene; 2005 Jan; 24(4):552-60. PubMed ID: 15580303
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.
Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS
Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
